目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Services
1.2.2. Biospecimen Type
1.2.3. Biobanks Type
1.2.4. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biobanks Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
3.2.1.2. Increased focus on precision medicine and genetic testing
3.2.1.3. Changes in biobanking operations
3.2.1.4. Increase in the number of clinical trials globally
3.2.1.5. Growing industry and research collaborations
3.2.1.6. Technology advancement and automation
3.2.2. Market restraint analysis
3.2.2.1. Disruptions in supply chain management due to COVID-19
3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.3. Sustainability challenges for biobanks
3.2.2.4. Other challenges in biobanking specimens for research
3.3. Biobanks Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Biobanks Market: Product & Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Product & Services Market Share, 2024 & 2030
4.3. Product
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Biobank Equipment
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Services
4.6. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.6.1. Biobanking & repository
4.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Lab processing
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Qualification/ Validation
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Cold Chain Logistics
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Other Services
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Biobanks Market: Biospecimen Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biospecimen Type Market Share, 2024 & 2030
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.3.1. Human Tissues
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.3.2. Human Organs
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Stem Cells
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.2. Adult Stem Cells
5.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.3. Embryonic Stem Cells
5.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.4. IPS Cells
5.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.5. Other Stem Cells
5.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Other biospecimens
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Biobanks Market: Biobanks Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biobanks Type Market Share, 2024 & 2030
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.3.1. Physical/Real biobanks
6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.3.1.2. Tissue Biobanks
6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.3. Population based biobanks
6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.4. Genetic (DNA/RNA)
6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.5. Disease based biobanks
6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Virtual biobanks
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Biobanks Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Application Market Share, 2024 & 2030
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.3.1. Therapeutics
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Drug discovery & clinical research
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Clinical Diagnostics
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Other Applications
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Biobanks Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework/ reimbursement structure
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework/ reimbursement structure
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Qiagen
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Hamilton Company
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Tecan Trading AG
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Danaher Corporation
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Becton, Dickinson, and Company (BD)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Biocision, LLC.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Taylor-Wharton
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Charles River Laboratories
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Lonza
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Stemcell Technologies
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. Biovault Family
9.4.13.1. Company overview
9.4.13.2. Financial performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. Promocell GmbH
9.4.14.1. Company overview
9.4.14.2. Financial performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives
9.4.15. Precision Cellular Storage Ltd. (Virgin Health Bank)
9.4.15.1. Company overview
9.4.15.2. Financial performance
9.4.15.3. Product benchmarking
9.4.15.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
Table 3 North America biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 4 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 5 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 6 North America biobanks market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 8 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 9 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 10 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
Table 11 Mexico biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 12 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 13 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 14 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
Table 15 Canada biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 16 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 17 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 18 Canada biobanks market, by application, 2018 - 2030 (USD Million)
Table 19 Europe biobanks market, by region, 2018 - 2030 (USD Million)
Table 20 Europe biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 21 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 22 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 23 Europe biobanks market, by application, 2018 - 2030 (USD Million)
Table 24 Germany biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 25 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 26 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 27 Germany biobanks market, by application, 2018 - 2030 (USD Million)
Table 28 UK biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 29 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 30 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 31 UK biobanks market, by application, 2018 - 2030 (USD Million)
Table 32 France biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 33 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 34 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 35 France biobanks market, by application, 2018 - 2030 (USD Million)
Table 36 Italy biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 37 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 38 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 39 Italy biobanks market, by application, 2018 - 2030 (USD Million)
Table 40 Spain biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 41 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 42 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 43 Spain biobanks market, by application, 2018 - 2030 (USD Million)
Table 44 Denmark biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 45 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 46 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 47 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
Table 48 Sweden biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 49 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 50 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 51 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
Table 52 Norway biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 53 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 54 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 55 Norway biobanks market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 58 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
Table 61 China biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 62 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 63 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 64 China biobanks market, by application, 2018 - 2030 (USD Million)
Table 65 Japan biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 66 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 67 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 68 Japan biobanks market, by application, 2018 - 2030 (USD Million)
Table 69 India biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 70 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 71 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 72 India biobanks market, by application, 2018 - 2030 (USD Million)
Table 73 South Korea biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 74 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 75 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 76 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
Table 77 Australia biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 78 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 79 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 80 Australia biobanks market, by application, 2018 - 2030 (USD Million)
Table 81 Thailand biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 82 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 83 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 84 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 86 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 87 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 88 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
Table 89 Brazil biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 90 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 91 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 92 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
Table 93 Argentina biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 94 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 95 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 96 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
Table 97 MEA biobanks market, by region, 2018 - 2030 (USD Million)
Table 98 MEA biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 99 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 100 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 101 MEA biobanks market, by application, 2018 - 2030 (USD Million)
Table 102 South Africa biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 103 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 104 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 105 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
Table 110 UAE biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 111 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 112 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 113 UAE biobanks market, by application, 2018 - 2030 (USD Million)
Table 114 Kuwait biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 115 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 116 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 117 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)

List of Tables
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Biobanks market: market outlook
Fig. 9 Biobanks competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Biobanks market driver impact
Fig. 15 Biobanks market restraint impact
Fig. 16 Biobanks market strategic initiatives analysis
Fig. 17 Biobanks market: Product & services movement analysis
Fig. 18 Biobanks market: Product & services outlook and key takeaways
Fig. 19 Product market estimates and forecast, 2018 - 2030
Fig. 20 Biobanking equipment market estimates and forecast, 2018 - 2030
Fig. 21 Temperature control systems estimates and forecast, 2018 - 2030
Fig. 22 Freezers & refrigerators market estimates and forecast, 2018 - 2030
Fig. 23 Cryogenic storage systems market estimates and forecast, 2018 - 2030
Fig. 24 Thawing equipment market estimates and forecast, 2018 - 2030
Fig. 25 Incubators & centrifuges market estimates and forecast, 2018 - 2030
Fig. 26 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
Fig. 27 Accessories & other equipment market estimates and forecast, 2018 - 2030
Fig. 28 Biobanking consumables market estimates and forecast, 2018 - 2030
Fig. 29 Laboratory information management systems market estimates and forecast, 2018 - 2030
Fig. 30 Services market estimates and forecasts, 2018 - 2030
Fig. 31 Biobanking & repository market estimates and forecasts, 2018 - 2030
Fig. 32 Lab processing market estimates and forecasts,2018 - 2030
Fig. 33 Qualification/ Validation market estimates and forecasts,2018 - 2030
Fig. 34 Cold chain logistics market estimates and forecasts, 2018 - 2030
Fig. 35 Other services market estimates and forecasts,2018 - 2030
Fig. 36 Biobanks market: Biospecimen type movement analysis
Fig. 37 Biobanks market: Biospecimen type outlook and key takeaways
Fig. 38 Human tissues market estimates and forecasts, 2018 - 2030
Fig. 39 Human organs market estimates and forecasts,2018 - 2030
Fig. 40 Stem cells market estimates and forecasts, 2018 - 2030
Fig. 41 Adult stem cells market estimates and forecasts,2018 - 2030
Fig. 42 Embryonic stem cells market estimates and forecasts, 2018 - 2030
Fig. 43 IPS cells market estimates and forecasts, 2018 - 2030
Fig. 44 Other stem cells market estimates and forecasts, 2018 - 2030
Fig. 45 Other biospecimens market estimates and forecasts, 2018 - 2030
Fig. 46 Biobanks market: Biobanks type movement analysis
Fig. 47 Biobanks market: Biobanks type outlook and key takeaways
Fig. 48 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
Fig. 49 Tissue biobanks market estimates and forecasts,2018 - 2030
Fig. 50 Population based biobanks market estimates and forecasts, 2018 - 2030
Fig. 51 Genetic (DNA/RNA) market estimates and forecasts,2018 - 2030
Fig. 52 Disease based biobanks market estimates and forecasts, 2018 - 2030
Fig. 53 Virtual biobanks market estimates and forecasts, 2018 - 2030
Fig. 54 Biobanks market: Application movement analysis
Fig. 55 Biobanks market: Application outlook and key takeaways
Fig. 56 Therapeutics market estimates and forecasts, 2018 - 2030
Fig. 57 Drug discovery & clinical research market estimates and forecasts,2018 - 2030
Fig. 58 Clinical diagnostics market estimates and forecasts, 2018 - 2030
Fig. 59 Other applications market estimates and forecasts,2018 - 2030
Fig. 60 Global Biobanks market: Regional movement analysis
Fig. 61 Global Biobanks market: Regional outlook and key takeaways
Fig. 62 North America, by country
Fig. 63 North America
Fig. 64 North America market estimates and forecasts, 2018 - 2030
Fig. 65 U.S. country dynamics
Fig. 66 U.S. market estimates and forecasts, 2018 - 2030
Fig. 67 Canada country dynamics
Fig. 68 Canada market estimates and forecasts, 2018 - 2030
Fig. 69 Mexico country dynamics
Fig. 70 Mexico market estimates and forecasts, 2018 - 2030
Fig. 71 Europe market estimates and forecasts, 2018 - 2030
Fig. 72 UK country dynamics
Fig. 73 UK market estimates and forecasts, 2018 - 2030
Fig. 74 Germany country dynamics
Fig. 75 Germany market estimates and forecasts, 2018 - 2030
Fig. 76 France country dynamics
Fig. 77 France market estimates and forecasts, 2018 - 2030
Fig. 78 Italy country dynamics
Fig. 79 Italy market estimates and forecasts, 2018 - 2030
Fig. 80 Spain country dynamics
Fig. 81 Spain market estimates and forecasts, 2018 - 2030
Fig. 82 Denmark country dynamics
Fig. 83 Denmark market estimates and forecasts, 2018 - 2030
Fig. 84 Sweden country dynamics
Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
Fig. 86 Norway country dynamics
Fig. 87 Norway market estimates and forecasts, 2018 - 2030
Fig. 88 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 89 China country dynamics
Fig. 90 China market estimates and forecasts, 2018 - 2030
Fig. 91 Japan country dynamics
Fig. 92 Japan market estimates and forecasts, 2018 - 2030
Fig. 93 India country dynamics
Fig. 94 India market estimates and forecasts, 2018 - 2030
Fig. 95 Thailand country dynamics
Fig. 96 Thailand market estimates and forecasts, 2018 - 2030
Fig. 97 South Korea country dynamics
Fig. 98 South Korea market estimates and forecasts, 2018 - 2030
Fig. 99 Australia country dynamics
Fig. 100 Australia market estimates and forecasts, 2018 - 2030
Fig. 101 Latin America market estimates and forecasts, 2018 - 2030
Fig. 102 Brazil country dynamics
Fig. 103 Brazil market estimates and forecasts, 2018 - 2030
Fig. 104 Argentina country dynamics
Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 107 South Africa country dynamics
Fig. 108 South Africa market estimates and forecasts, 2018 - 2030
Fig. 109 Saudi Arabia country dynamics
Fig. 110 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 111 UAE country dynamics
Fig. 112 UAE market estimates and forecasts, 2018 - 2030
Fig. 113 Kuwait country dynamics
Fig. 114 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 115 Market position of key market players- Biobanks market